EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3

Pavel S Grudinkin1, Valery V Zenin, Andrey V Kropotov

  • 1Department of Intracellular Signalling and Transport, Institute of Cytology RAS, 194064 St. Petersburg, Russia. paulsg@rbcmail.ru

Insights

Epidermal Growth Factor (EGF) normally inhibits A431 cancer cell growth. This study reveals that Signal Transducer and Activator of Transcription 1 (STAT1) is crucial for this EGF-induced apoptosis, with STAT1 phosphorylation mediating the effect.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • High concentrations of Epidermal Growth Factor (EGF) inhibit the growth of human epidermoid carcinoma cells (A431).
  • The transcription factor Signal Transducer and Activator of Transcription 1 (STAT1) is implicated in mediating this EGF-induced growth inhibition.

Purpose of the Study:

  • To investigate the role of STAT1 in EGF-mediated growth inhibition and apoptosis in A431 cells.
  • To determine if STAT1 phosphorylation is essential for the anti-proliferative effects of EGF.

Main Methods:

  • Generated EGF-resistant A431 sub-clones and reintroduced wild-type or mutant STAT1.
  • Utilized short hairpin RNA (shRNA) to knock down STAT1 and STAT3 expression in A431 cells.
  • Assessed cell growth, apoptosis, and STAT1/STAT3 tyrosine phosphorylation levels.

Main Results:

  • EGF-resistant cells showed reduced STAT1 expression; reintroducing wild-type STAT1 restored EGF sensitivity.
  • STAT1 knockdown prevented EGF-induced apoptosis and allowed continued cell growth.
  • Blocking Src family kinases reduced STAT1/STAT3 phosphorylation and protected cells from EGF-induced growth inhibition.

Conclusions:

  • Tyrosine-phosphorylated STAT1, not STAT3, is essential for EGF-induced apoptosis in A431 cells.
  • STAT1 plays a critical role in mediating the growth-inhibitory and apoptotic effects of EGF in this cancer cell line.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...